SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lifecell (LIFC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (362)7/23/1999 5:37:00 PM
From: JEB  Read Replies (1) of 395
 
I have done some DD and please correct me if I'm wrong. LIFC has a strong buy rating from Gruntal & Co.. LIFC has a buy rating from Multex and a 2.0 AQO rating (S&P has a .93 AQO rating). BSX owns shares in LIFC according to a $1 Million equity investment deal and BSX has distribution rights to sell their skin matrix for gynecological and urological use worldwide.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News